NEW YORK (GenomeWeb News) – Bruker and Nextval are collaborating on the high-throughput screening of drugs and their metabolites using both companies' platforms, Bruker announced today.

Bruker's ultrafleXtreme MALDI-TOF/TOF mass spectrometer and Nextval's MassInsight technology will be used in the partnership.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.